105 related articles for article (PubMed ID: 1716792)
1. Absence of side effects of hydroxyethylstarch 200 in a porcine model of experimental arterial thrombosis.
Samama CM; Bonneau M; Bailliart O; Pignaud G; Scrobohaci ML; Caen JP; Viars P; Drouet LO
Thromb Res; 1991 Jun; 62(5):591-8. PubMed ID: 1716792
[No Abstract] [Full Text] [Related]
2. Neurotoxicity of intrathecal 6% hydroxyethyl starch 130/0.4 injection in a rat model.
Vassal O; Del Carmine P; Beuriat PA; Desgranges FP; Gadot N; Allaouchiche B; Timour-Chah Q; Stewart A; Chassard D
Anaesthesia; 2015 Sep; 70(9):1045-51. PubMed ID: 25907209
[TBL] [Abstract][Full Text] [Related]
3. [Blood volume replacement using hydroxyethyl starch or Dextran 60].
Hölscher B
Infusionstherapie (1973); 1974 Apr; 1(4):281-5. PubMed ID: 4142945
[No Abstract] [Full Text] [Related]
4. Effects of plasma expanders on coagulation and hemostasis: dextran hydroxyethyl starch, and other macromolecules revisited.
Alexander B
Prog Clin Biol Res; 1978; 19():293-330. PubMed ID: 78500
[No Abstract] [Full Text] [Related]
5. Relative Risks of Thrombosis and Bleeding in Different ABO Blood Groups.
Franchini M; Lippi G
Semin Thromb Hemost; 2016 Mar; 42(2):112-7. PubMed ID: 26716497
[TBL] [Abstract][Full Text] [Related]
6. [High plasma levels of factor VIII and von Willebrand factor in a patient with portal vein thrombosis].
Günther R; Fölsch UR
Z Gastroenterol; 2002 Jun; 40(6):409-12. PubMed ID: 12055664
[TBL] [Abstract][Full Text] [Related]
7. Highly substituted hydroxyethyl starch (HES200/0.62) leads to Type-I von Willebrand syndrome after repeated administration.
Treib J; Haass A; Pindur G; Miyachita C; Grauer MT; Jung F; Wenzel E; Schimrigk K
Haemostasis; 1996; 26(4):210-3. PubMed ID: 8872132
[TBL] [Abstract][Full Text] [Related]
8. Increased haemorrhagic risk after repeated infusion of highly substituted medium molecular weight hydroxyethyl starch.
Treib J; Haass A; Pindur G; Grauer MT; Jung F; Wenzel E; Schimrigk K
Arzneimittelforschung; 1997 Jan; 47(1):18-22. PubMed ID: 9037438
[TBL] [Abstract][Full Text] [Related]
9. [Antishock blood substitute based on hydroxyethyl starch].
Polushina TV; Prostakova TM; Bogino NA
Probl Gematol Pereliv Krovi; 1980 Mar; 25(3):40-4. PubMed ID: 6154296
[No Abstract] [Full Text] [Related]
10. Recombinant factor VIII SQ--stability of VIII: C in homogenates from porcine, monkey and human subcutaneous tissue.
Fatouros A; Lidén Y; Sjöström B
J Pharm Pharmacol; 2000 Jul; 52(7):797-805. PubMed ID: 10933130
[TBL] [Abstract][Full Text] [Related]
11. Hypertonic saline hydroxyethylstarch restores right ventricular-arterial coupling after normovolemic hemodilution in piglets.
Kerbaul F; Rondelet B; Bénas V; Grisoli D; De Waroquier A; Fesler P; Fusai T; Brimioulle S
Anesthesiology; 2011 Jul; 115(1):136-43. PubMed ID: 21587062
[TBL] [Abstract][Full Text] [Related]
12. von Willebrand Factor/Factor VIII adsorption to surfaces from human plasma.
Horbett TA; Counts RB
Thromb Res; 1984 Dec; 36(6):599-608. PubMed ID: 6442015
[TBL] [Abstract][Full Text] [Related]
13. Acquired factor VIII and von Willebrand factor (aFVIII/VWF) deficiency and hypothyroidism in a case with hypopituitarism.
Oliveira MC; Kramer CK; Marroni CP; Leães CG; Viana L; Roithman S; Schmaedecke A; Pereira-Lima JF
Clin Appl Thromb Hemost; 2010 Feb; 16(1):107-9. PubMed ID: 18550587
[TBL] [Abstract][Full Text] [Related]
14. High Factor VIII and Von Willebrand Factor Levels Are Not Risk Factors of Cryptogenic Arterial Ischemic Stroke in Thai Children.
Sirachainan N; Boonyatarp M; Kadegasem P; Sasanakul W; Visudtibhan A; Natesirinilkul R; Chuansumrit A; Wongwerawattanakoon P
J Child Neurol; 2015 Jul; 30(8):1057-9. PubMed ID: 25038134
[TBL] [Abstract][Full Text] [Related]
15. Von Willebrand's disease.
Hoyer LW
Prog Hemost Thromb; 1976; 3():231-87. PubMed ID: 781732
[No Abstract] [Full Text] [Related]
16. Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand disease.
De Meyer SF; Vandeputte N; Pareyn I; Petrus I; Lenting PJ; Chuah MK; VandenDriessche T; Deckmyn H; Vanhoorelbeke K
Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1621-6. PubMed ID: 18556568
[TBL] [Abstract][Full Text] [Related]
17. Von Willebrand factor--two sides and the edge of a coin.
Rangarajan S
Haemophilia; 2011 Jan; 17(1):61-4. PubMed ID: 20518815
[TBL] [Abstract][Full Text] [Related]
18. rFVIIa and NN1731 reduce bleeding in hydroxyethyl starch hemodiluted rabbits.
Lauritzen B; Viuff D; Tranholm M; Ezban M
J Trauma; 2010 Nov; 69(5):1196-202. PubMed ID: 20032791
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy in women with type 1 von Willebrand disease caused by heterozygosity for von Willebrand factor mutation C1130F.
Castaman G; Eikenboom JC; Contri A; Rodeghiero F
Thromb Haemost; 2000 Aug; 84(2):351-2. PubMed ID: 10959713
[No Abstract] [Full Text] [Related]
20. [Physico-chemical and biological properties of a new plasma substitute based on hydroxyethylated starch].
Kudriashov LI; Dombrovskiĭ VA; Alekseeva GS; Iarovaia SM; Chlenov MA
Bioorg Khim; 1986 Jun; 12(6):812-8. PubMed ID: 2430577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
